Literature DB >> 11389136

Processive phosphorylation of p130Cas by Src depends on SH3-polyproline interactions.

P Pellicena1, W T Miller.   

Abstract

Many in vivo substrates of Src family tyrosine kinases possess sequences conforming to Src homology 2 and 3 (SH2 and SH3) domain-binding motifs. One such substrate is p130Cas, a protein that is hyperphosphorylated in v-Src transformed cells. Cas contains a substrate domain consisting of 15 potential tyrosine phosphorylation sites, C- and N-terminal polyproline regions fitting the consensus sequence for SH3 domain ligands, and a YDYV motif that binds the Src SH2 domain when phosphorylated. In an effort to understand the mechanisms of processive phosphorylation, we have explored the regions of Cas necessary for interaction with Src using the yeast two-hybrid system. Mutations in the SH2 domain-binding region of Cas or the Src SH2 domain have little effect in Cas-Src complex formation or phosphorylation. However, disruption of the C-terminal polyproline region of Cas completely abolishes interaction between the two proteins and results in impaired phosphorylation of Cas. Kinetic analyses using purified proteins indicated that multisite phosphorylation of Cas by Src follows a processive rather than a distributive mechanism. Furthermore, the kinetic studies show that there are two properties of the polyproline region of Cas that are important in enhancing substrate phosphorylation. First, the C-terminal polyproline serves to activate Src kinases through the process of SH3 domain displacement. Second, this region aids in anchoring the kinase to Cas to facilitate processive phosphorylation of the substrate domain. The two processes combine to ensure phosphorylation of Cas with high efficiency.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389136     DOI: 10.1074/jbc.M100055200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

Review 1.  Catalytic mechanisms and regulation of protein kinases.

Authors:  Zhihong Wang; Philip A Cole
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

Review 2.  Determinants of substrate recognition in nonreceptor tyrosine kinases.

Authors:  W Todd Miller
Journal:  Acc Chem Res       Date:  2003-06       Impact factor: 22.384

3.  Individual Cas phosphorylation sites are dispensable for processive phosphorylation by Src and anchorage-independent cell growth.

Authors:  Parag Patwardhan; Yongquan Shen; Gary S Goldberg; W Todd Miller
Journal:  J Biol Chem       Date:  2006-05-17       Impact factor: 5.157

Review 4.  Processive phosphorylation: mechanism and biological importance.

Authors:  Parag Patwardhan; W Todd Miller
Journal:  Cell Signal       Date:  2007-06-22       Impact factor: 4.315

5.  Distributivity and processivity in multisite phosphorylation can be distinguished through steady-state invariants.

Authors:  Jeremy Gunawardena
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

6.  Programming with models: modularity and abstraction provide powerful capabilities for systems biology.

Authors:  Aneil Mallavarapu; Matthew Thomson; Benjamin Ullian; Jeremy Gunawardena
Journal:  J R Soc Interface       Date:  2009-03-06       Impact factor: 4.118

7.  Cooperative activation of Src family kinases by SH3 and SH2 ligands.

Authors:  Shalini S Yadav; W Todd Miller
Journal:  Cancer Lett       Date:  2007-08-24       Impact factor: 8.679

8.  Src, p130Cas, and Mechanotransduction in Cancer Cells.

Authors:  Hiroyuki Matsui; Ichiro Harada; Yasuhiro Sawada
Journal:  Genes Cancer       Date:  2012-05

9.  SRC points the way to biomarkers and chemotherapeutic targets.

Authors:  Harini Krishnan; W Todd Miller; Gary S Goldberg
Journal:  Genes Cancer       Date:  2012-05

10.  Processive phosphorylation of alternative splicing factor/splicing factor 2.

Authors:  Brandon E Aubol; Sutapa Chakrabarti; Jacky Ngo; Jennifer Shaffer; Brad Nolen; Xiang-Dong Fu; Gourisankar Ghosh; Joseph A Adams
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.